Hydroxychloroquine The Potential Covid 19 Cure

In 2020, the President of the United States of America made a claim that Hydroxychloroquine could be used as a treatment for Covid 19. The FDA authorized the emergency use of hydroxychloroquine in March 2020. A week later Donald Trump endorsed the drug as a potential Covid-19 treatment and the government stockpiled millions of doses. The President only made his statement after being briefed by the FDA that it was indeed a 'game changer'. The 'Left Wing' element of US politics and news, then quickly jumped on this statement to use this as a weapon against the former President. A study was released by infectious-disease researchers in New Jersey. The researchers studied 255 patients at Saint Barnabas Medical Center in Livingston, N.J., during the early months of the pandemic. They conclude that a combination of hydroxychloroquine and azithromycin at certain levels translates to "a survival rate 2.9 times the other patients." Trump himself recently released a list of things "they are now admitting I was right about" that included, with no qualification, "Hydroxychloroquine works." Hydroxychloroquine, the malaria drug touted as a "game changer" magical Covid-19 cure by former US President Donald Trump in 2020, has been found effective in a prophylactic study published in the Journal of The Association of Physicians of India. Hydroxychloroquine may have become politicized in the US but India uses it widely. "It's the politicization of this medicine by the mainstream media and portions of the medical community that somehow made this a battle between President (Donald) Trump and them, and created this undue fear and hysteria over a drug, a medicine that has been used for over 60 years relatively safely and is regularly prescribed to pregnant women if they are going to a malaria zone," White House Office of Trade and Manufacturing Policy Director Peter Navarro told reporters. "The idea that this is a dangerous drug is just silly, but if you ask the American people based on the media's coverage of it, that is kind of the state of play right now," he said. Navarro said four doctors at the Detroit Hospital System filed a request for emergency use authorization for hydroxychloroquine. The request was for three things; "One, for early treatment use in a hospital setting. Number two, treatment between a doctor and his patient in an outpatient setting. Three, not just as a therapeutic but also as a possible prophylaxis for preventative use," he said.

Does Hydroxychloroquine work? Does Ivermectin work? It seems that from 2020 and now with the variants, we are suffering from a world-wide nightmare that only Joe Biden thinks has ended. So far, when it seems like it is over, the end point gets stretched out—often past the point of human tolerance. The FDA has flip flopped on both Hydroxychloroquine and Ivermectin for COVID but both are approved for Malaria. Hydroxychloroquine is also marketed as Plaquenil for Lupus and Ivermectin is marketed as Stromectol for intestinal strongyloidiasis due to the nematode parasite. The FDA has approved the antiviral drug remdesivir (Veklury) to treat COVID-19 in hospitalized adults and children who are age 12 and older in the hospital. The FDA has granted an emergency use authorization for the rheumatoid arthritis drug baricitinib (Olumiant) to treat COVID-19 in some cases. Hydroxychloroquine and chloroquine are two medications that have been used for many decades to treat malaria and autoimmune conditions like rheumatoid arthritis and lupus. The official word is that based on the available medical data at this time, hydroxy-chloroquine and chloroquine are not effective for treating or preventing COVID-19. The same goes for Ivermectin. Many doctors swear by it but it still has not made it to an official recommended list. Even New Yorkers and others from big cities who thought they could find solace in their lakeside or mountain retreats to escape the contagion of the big city, have had to go underground in their cabins as their new small-town neighbors are being interviewed on local radio & TV complaining of them bringing the big city virus to their small burgs. Now, what? It is called novel, meaning new, and because of its newness, there are no cookbook cures for this plague. And so, death is often a result of a long illness with this virus. Too many deaths! So what to do? In this book we tell you about how this virus got its start and how it made its way across the world in record time. We talk about the measures the world has taken to keep us all safe and we tell you about some promising therapeutics that in some cases are reported to cure the virus and in other cases, they are reported to serve as a prophylaxis to prevent people from contracting the potentially deadly virus. Nobody knows for sure whether anything will work. But some doctors swear by some of the old stand-bys. We wrap this book up by offering a very simple way to be OK--sooner , not later. In this book, your author gives us all a few tips that in his opinion can get us rolling & relieve the frustration safely. You won’t know about what is being said about if it can work until you read about it here. You’ll find I think some people ought to go to jail for killing Americans. In all cases before you take anything. See your own doctor first.

PLEASE BE AWARE. THIS IS A BOOK. NOT THE ACTUAL MEDICATION. Much has been said about the drug "Hydroxychloroquine" and its use in the fight against Covid 19. So before an educated decision is made by yourself with its usage. We suggest an examination of the facts. Hydroxychloroquine is indeed a drug that has been suggested can be used against Covid 19. Hydroxychloroquine, sold under the brand name Plaquenil among others, is a medication used to prevent and treat malaria in areas where malaria remains sensitive to chloroquine. Other uses include treatment of rheumatoid arthritis, lupus, and porphyria cutanea tarda. It is taken by mouth, often in the form of hydroxychloroquine sulfate. Hydroxychloroquine was approved for medical use in the United States in 1955. It is on the World Health Organization's List of Essential Medicines. In 2018, it was the 129th most commonly prescribed medication in the United States, with more than 5 million prescriptions.

SARS is a newly identified human infection caused by a corona virus unlike any other known human or animal virus in its family. The analysis of epidemiological information obtained from the sites of the outbreaks of SARS is still underway but the overall case fatality ratio is known to approach 11% although the rate among the elderly is much higher. Currently the major challenges for the treatment of SARS are: the source of the SARS virus and mode of transmission are still not well understood; there are problems with diagnostic tools; there is no effective treatment; and there is no vaccine for SARS. The above-mentioned difficulties and challenges have motivated national authorities health workers and scientists to explore the potential of complementary treatment. The results of research on integrated treatment with TCM and Western medicine showed that it is safe and that it also has some potential clinical benefits. Therefore the experts suggested that records of such experience could serve as reference material for treatment of SARS in the future. This publication is intended to share experience in the complementary treatment of SARS patients; share the experience of clinical studies in the field of traditional medicine for treatment of SARS between the physicians and researchers; and to further encourage and promote the quality of research in the filed of traditional medicine.

The second revised edition of model prescribing information for some 37 essential drugs used for the prevention and treatment of protozoal and helminthic infections. The sections on malaria, African trypanosomiasis, cestode infections, schistosomiasis, and onchocerciasis have been extensively revised in the light of new developments in the treatment of these diseases. The book is organized according to diseases, moving from amoebiasis and giardiasis to intestinal, liver, and lung flukes. Each disease or group of diseases is first introduced with concise information about its causes, mode of transmission, clinical features, and geographical prevalence, followed by general advice on prevention and treatment. Prescribing information is then provided for first-choice and alternative therapeutic and prophylactic drugs. Information includes uses, dosage and administration, contraindications and precautions, use in pregnancy, adverse effects, drug interactions, and advice on storage. Wherever relevant, prescribing precautions to be followed when treating infections in AIDS patients are clearly indicated. Some rarer parasitic diseases, such as Babesia divergens infections and meningoencephalitis due to Acanthamoeba spp, which do not respond to chemotherapy, are nonetheless presented and discussed in order to help prescribers avoid ineffective medications.

Malpractice settlements are large for undetected hydroxychloroquine and chloroquine toxicity which, if untreated, can lead to permanent loss of central vision. Knowledge of the ocular toxicity of these drugs has increased during the past fifty years as their use has expanded. Hydroxychloroquine and Chloroquine Retinopathy is the first single-source book on the subject and is essential for the practicing ophthalmologists, rheumatologists, dermatologists, and internists who prescribe these drugs. It covers clinical topics such as signs and symptoms of toxicity, toxicity screening, ancillary testing, to whom and why the drugs are prescribed and dosing considerations. Additionally, the book addresses practice management considerations, including coding, reimbursement and equipment costs, and the medico-legal responsibilities of the rheumatologist and of the ophthalmologist. Guidelines for the management of hydroxychloroquine and chloroquine vary around the world and differences between the guidelines of the United Kingdom, the United States, and other countries are identified. The book concludes with a collection of case examples illustrating common clinical scenarios and their management. This book is a “must-have” resource for physicians who use these drugs.

This book provides a comprehensive overview of recent novel coronavirus (SARS-CoV-2) infection, their biology and associated challenges for their treatment and prevention of novel Coronavirus Disease 2019 (COVID-19). Discussing various aspects of COVID-19 infection, including global epidemiology, genome organization, immunopathogenesis, transmission cycle, diagnosis, treatment, prevention, and control strategies, it highlights host-pathogen interactions, host immune response, and pathogen immune invasion strategies toward developing an immune intervention or preventive vaccine for COVID-19. An understanding of the topics covered in the book is imperative in the context of designing strategies to protect the human race from further losses and harm due to SARS-CoV-2 infection causing COVID-19.

This work has been selected by scholars as being culturally important, and is part of the knowledge base of civilization as we know it. This work was reproduced from the original artifact, and remains as true to the original work as possible. Therefore, you will see the original copyright references, library stamps (as most of these works have been housed in our most important libraries around the world), and other notations in the work. This work is in the public domain in the United States of America, and possibly other nations. Within the United States, you may freely copy and distribute this work, as no entity (individual or corporate) has a copyright on the body of the work. As a reproduction of a historical artifact, this work may contain missing or blurred pages, poor pictures, errant marks, etc. Scholars believe, and we concur, that this work is important enough to be preserved, reproduced, and made generally available to the public. We appreciate your support of the preservation process, and thank you for being an important part of keeping this knowledge alive and relevant.